✦ LIBER ✦

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer

✍ Scribed by Gabriella Ferrandina; Franco O Ranelletti; Enrica Martinelli; Amelia Paglia; Gian Franco Zannoni; Giovanni Scambia

Book ID: 115010825
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 289 KB
Volume: 6
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-6-182

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Her-2/neu expression in ovarian cancer:

Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy

✍ Prema P Peethambaram; William A Cliby; Gregory Lubiniecki; Amy C Clayton; Patric 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 683 KB

BRCA1/2 mutations and expression: Respon

BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer

✍ Rebecca Byler Dann; Julie A. DeLoia; Kirsten M. Timms; Kristin K. Zorn; Jennifer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 329 KB

FANCD2 Expression in Advanced Non–Small-

FANCD2 Expression in Advanced Non–Small-Cell Lung Cancer and Response to Platinum-Based Chemotherapy

✍ Miriam Ferrer; Simone W. Span; Barbara Vischioni; Joost J. Oudejans; Paul J. van 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 507 KB

Calpain-2 expression is associated with

Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer

✍ Sarah J. Storr; Sabreena Safuan; Caroline M. Woolston; Tarek Abdel-Fatah; Suha D 📂 Article 📅 2012 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 335 KB

Phase 2 Study of TLK286 (GST P1-1 Activa

Phase 2 Study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A phase III randomized trial of BAY 12-9

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study

✍ H. Hirte; I.B. Vergote; J.R. Jeffrey; R.N. Grimshaw; S. Coppieters; B. Schwartz; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB